“国寿臻爱无忧悦享版”全新上市

Core Viewpoint - China Life Insurance has launched a new mid-range medical insurance product, "Guoshou Zhenai Wuyou Medical Insurance (Yuexiang Version)," in response to national policy directions and public health demands, providing diverse and flexible medical coverage options for the public [1][9]. Group 1: Product Features - The new insurance product emphasizes "quality medical care" with eight upgraded core advantages, enhancing the medical coverage system [1]. - It expands medical service scenarios, covering various public hospital departments, allowing customers to choose medical institutions based on their needs for a more comfortable and efficient experience [1]. - The product includes an outpatient "dual-channel" drug reimbursement feature, addressing the growing demand for medication and easing financial burdens for customers purchasing specific drugs outside hospitals [2]. - It optimizes coverage design to enhance practicality, covering hospitalization, outpatient services, and reducing deductibles to improve accessibility and reliability [3]. - The product offers additional financial support for major illness patients, alleviating initial financial impacts on families [4]. - It incorporates advanced treatment methods, including specific drugs for severe cancer, proton therapy, CAR-T therapy, and gene testing, providing more treatment options for patients [5]. - It provides fixed subsidies for families during high-cost treatments in intensive care units, helping to ease economic pressures [6]. - The insurance includes rehabilitation coverage post-treatment, ensuring quality recovery and improving post-illness life quality [8]. - The age range for policyholders is broad, covering individuals from 28 to 70 years old, with the option to renew coverage up to age 100 [9]. Group 2: Company Commitment - China Life Insurance aims to fulfill its social responsibility by actively participating in the national healthcare system and addressing public health needs through innovative product offerings [9]. - The company emphasizes its role as a stabilizing force in the economy and society, contributing to the multi-tiered medical insurance system in China [9]. - Future plans include continuous product innovation and service quality enhancement, collaborating with medical institutions to promote quality healthcare development [9].